Evidence map›Paper›PMID 42620962›Full record

ArticleFrontiers in oncology2026

Diffuse glioma perfusion quantification with ASL and DSC: a head-to-head comparison with

Jan Petr, Niels Verburg, Joost P A Kuijer, Thomas Koopman, Vera C Keil, Esther A H Warnert, Frederik Barkhof, Joerg van den Hoff, Ronald Boellaard, Philip C De Witt Hamer and 1 more

Abstract read
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jan Petr *Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany.
Niels Verburg *Department of Neurosurgery, Amsterdam University Medical Center, Amsterdam, Netherlands.
Joost P A KuijerDepartment of Radiology and Nuclear Medicine, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Thomas KoopmanDepartment of Radiology and Nuclear Medicine, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Vera C KeilDepartment of Radiology and Nuclear Medicine, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Esther A H WarnertDepartment of Radiology and Nuclear Medicine, Erasmus Medical Center, Rotterdam, Netherlands.
Frederik BarkhofDepartment of Radiology and Nuclear Medicine, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Joerg van den HoffHelmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany.
Ronald BoellaardDepartment of Radiology and Nuclear Medicine, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Philip C De Witt HamerDepartment of Neurosurgery, Amsterdam University Medical Center, Amsterdam, Netherlands.
Henk J M M MutsaertsDepartment of Radiology and Nuclear Medicine, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and purpose: Arterial spin labeling (ASL) is a non-invasive alternative to dynamic susceptibility contrast (DSC) for measuring cerebral blood flow (CBF), even though both methods measure slightly different contrast. This study compares ASL and DSC MRI with the gold-standard measurement Methods: Eight patients (age 40.5 ± 17.0 years, 3 women) with grade 2-4 gliomas were scanned at 3T MRI with ASL and DSC, and at PET using a Results: ASL showed superior (p<0.001) voxel-wise agreement with PET (MRE 26.8%) in the normal-appearing tissue compared with DSC (MRE 33.8%). While the tumor maximum CBF normalized to contralateral gray matter comparison with PET did not differ between (p=0.5) ASL (MRE 23.2%) and DSC (MRE 22.0%), voxel-wise agreement was better (p<0.001) for ASL (MRE 27.2%) than for DSC (MRE 35.0%). Visually, ASL overestimated CBF near larger arteries, and DSC underestimated CBF in non-enhancing tumors with tiny capillaries. Conclusion: While neither ASL nor DSC is fully comparable to

Indexed as

ASLDSCgliomaperfusionPET

Identifiers

PMID42620962
PMCPMC13485800

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.